We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,699.00
Bid: 1,699.00
Ask: 1,699.50
Change: -6.00 (-0.35%)
Spread: 0.50 (0.029%)
Open: 1,705.00
High: 1,711.00
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Women struggling to crack glass ceiling in top UK companies-report

Wed, 26th Mar 2014 15:17

* Women now hold fifth of FTSE 100 board positions

* Few women on executive committees with only 4 CEOs

* Campaigners push for voluntary change, not quotas (Adds new quotes, numbers, after report launch)

By Belinda Goldsmith

LONDON, March 26 (Reuters) - More women are sitting on theboards of Britain's blue-chip companies but the glass ceilingis yet to crack, with most top jobs still held by men andcompanies needing to do more to promote women, a governmentreport said on Wednesday.

The third annual progress report found women now occupy afifth, or 20.7 percent, of positions in FTSE 100 companies, upfrom 12.5 percent in 2011, within striking distance of a targetfor women to account for one quarter of board seats by 2015.

But campaigners admitted there was still a long way to go aswomen only account for 6.9 percent of senior executive roles inthe FTSE 100 where there are only four women chief executives.

Two companies in the FTSE 100, commodities trader GlencoreXstrata and miner Antofagasta, still haveall-male boards - although they told Reuters they are seekingfemale directors - and 48 FTSE 250 companies have all-maleboards.

Former trade minister Mervyn Davies, leader of thegovernment initiative since 2011, said the figures showed avoluntary drive to boost women around the boardroom table wasworking and ruled out the need for mandatory quotas such asthose introduced in France, Italy, Spain and the Netherlands andplanned for Germany.

He said the key to lasting improvement was encouragingcompanies to drive change within, not legislation or governmentintervention that critics argue can lead to tokenism and "trophydirectors".

"This is about changing the culture of corporate Britain,and using a stick is not the best way to do that," Davies toldReuters after launching the latest report in London.

"Everyone now sees that (having more women on boards) isgreat business sense so the debate is now moving from theboardroom to executive committees."

BUSINESS CREDIBILITY

He said Britain was leading the way at driving corporatechange on a voluntary basis rather than with quotas which arenow being mulled in the European Union.

But he said companies whether public or private had to stepup to the mark and he has written to all companies in the FTSE350 urging them to find ways to boost female representation.

"Failure would again raise the unwelcome proposal ofcompulsory measures. British business credibility is at stakeand we need to redouble our efforts," Davies said.

Minister for Women Maria Miller said companies needed to behonest that the culture in Britain was not neutral and it wasstill "white, male and heterosexual".

The only FTSE 100 female CEOs are Moya Greene at Royal Mail, Carolyn McCall at easyJet, Angela Ahrendts atBurberry and Alison Cooper at Imperial Tobacco.

Capita and Diageo had the highest proportionof women among FTSE 100 boards at 44 percent, followed by RoyalMail, Unilever, and GlaxoSmithKline.

Miller said corporate change was needed to address genderimbalance as well as the pay gap between men and women and ruleson executive pay.

"Women don't need special treatment. They just need an equalplaying field," she said.

With the spotlight on promoting women, several British banksreleased targets on gender balance in their annual results forthe first time this year.

HSBC aims to have women in 25 percent of seniorroles by 2014/15, up from 22.7 percent; Lloyds has atarget of 40 percent by 2020 compared to 28 percent now; andBarclays is eyeing 26 percent by 2018, up 5 points.

Davies, the former chief executive of Standard Chartered, said it was "inconceivable in this day and age" tohave an all-male board or executive committee.

"A company that does not get the mood of society on thisissue actually deserves to go out of business," he said. (Additional reporting by Steve Slater, Editing by AlisonWilliams)

More News
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more
26 Oct 2023 09:19

TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China

(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.